ONVO - Organovo Holdings Profit before interest, taxes and amortization

Brandmark of Organovo (ONVO)

Organovo Holdings, Inc. (ONVO) operates in the bioprinting niche, where the market remains skeptical of long investment payback periods. Operating profit dynamics reflect current financial results, with the metric standing at . Growth potential is based on the creation of liver models for therapy, although the business remains sensitive to the availability of venture financing.

Organovo Holdings Inc - ONVO Operating profit EBITDA (period 07/04/2022 - 11/18/2026)

Summary analytical data breakdowns for organovo.com (ONVO)

Analysis of all company metrics:Organovo Holdings, Inc. (ONVO)
Manufactured products of Organovo Holdings, Inc.

The development of 3D bioprinting by Organovo Holdings, Inc. (ONVO) within a protected US scientific perimeter ensures a stable operating environment free from external geopolitical risks. The trend in net operating income before depreciation reflects the actual cash flow from core operations, allowing investors to distinguish actual profitability from accounting adjustments and assess capitalization transparency through continuous growth in cash inflows.

Who Organovo Holdings, Inc. competes with

ASND - Operating profit before deduction of amortization|Madrigal Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Corcept|RYTM (Rhythm Pharmaceuticals, Inc.) - Operating profit before deduction of amortization|AKRO: Company profit before taxes, interest and amortization|MTSR (Metsera Therapeutics) - Operating profit EBITDA|Operating profit EBITDA MoonLake Immunotherapeutics|Operating profit EBITDA CRNX|Profit before payment of interest, taxes and amortization NAMS (NewAmsterdam Pharma Company)|Profit before payment of interest, taxes and amortization soleno.life SLNO|Amicus Corp (FOLD) - Profit before interest, taxes and amortization|ETNB - Profit before payment of interest, taxes and amortization|AGIO: Profit before payment of interest, taxes and amortization|GPCR: Operating profit EBITDA|MDXG - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Rezolute Bio|Lexicon Corp (LXRX) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization mbxbio.com (MBX)|Operating profit EBITDA altimmune.com (ALT)|Operating profit EBITDA AARD (aardvarktherapeutics.com)|Operating income before deduction of amortization Sagimet Biosciences Inc. (SGMT)|BioAge Labs, Inc - Operating profit EBITDA|Operating income before deduction of amortization Biomea Fusion Corp BMEA|QNCX: Operating profit EBITDA|Fractyl Health, Inc. (GUTS) - Operating profit EBITDA|Operating profit before deduction of amortization VTVT|Agape ATP Corporation - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA PLUR|SYBX - Profit before interest, taxes and amortization|Operating profit EBITDA LPCN (lipocine.com)|Operating profit EBITDA Matinas BioPharma MTNB|SPRB: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Galecto Corp|CTCX (Carmell Corp) - Operating profit before deduction of amortization|Lumos Pharma Corp - Income before deduction of interest, taxes and amortization|RDUS (Radius Recycling Inc.) - Operating profit EBITDA